Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Risk of Multiple System Atrophy and the Use of Anti-Inflammatory Drugs: A Danish Register-Based Case-Control Study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Resting Heart Rate Is Not Associated with Cognitive Function

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Strategies to Improve Stroke Care Services in Low- and Middle-Income Countries: A Systematic Review

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Clinical Features in a Danish Population-Based Cohort of Probable Multiple System Atrophy Patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Gene-Environment Interaction in Parkinson's Disease: Coffee, ADORA2A, and CYP1A2

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Atlas of the Global Burden of Stroke (1990-2013): The GBD 2013 Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

INTRODUCTION: Multiple system atrophy (MSA) is a rare rapidly progressive atypical Parkinson disorder presenting clinically with parkinsonism and/or a cerebellar syndrome in combination with dysautonomia. Severe neuroinflammation develops along with hallmark neuropathological changes, and as in Parkinson's disease, intake of anti-inflammatory medication has been hypothesized to be protective for development of disease. We aimed to investigate if use of non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs), low-dose aspirin, or statins were associated with a reduced risk of MSA.

METHODS: We performed a register-based case-control study in MSA (n = 155) cases and population controls (n= 7,750) matched on age, gender, and place of residency by risk-set sampling. Pharmacological exposure prior to diagnosis was assessed in 2 categories (user vs. nonuser, cumulated dose in tertiles [T1-T3]). In an unconditional logistic regression model, adjusted for age, gender, residency, and chronic obstructive pulmonary disease (COPD), we estimated ORs and 95% CIs.

RESULTS: Data suggested a trend towards non-aspirin NSAID use to be associated with a decreased risk of MSA (OR 0.72 [95% CI 0.49-1.06]) compared to nonusers, decreasing dose-dependently (T2 OR 0.77 [95% CI 0.43-1.38]; T3 OR 0.55 [95% CI 0.29-1.06]). However, data were based on small numbers. Use of statins and low-dose aspirin was not associated with a decreased risk of MSA. Results were lagged 5 years from index date to address reverse causation.

CONCLUSION: A trend toward use of non-aspirin NSAID and an associated reduced risk of MSA was observed in this study. However, our analyses had limited statistical precision, and further studies including larger sample sizes and longer exposure periods are needed.

OriginalsprogEngelsk
TidsskriftNeuroepidemiology
Vol/bind54
Udgave nummer1
Sider (fra-til)58-63
Antal sider6
ISSN0251-5350
DOI
StatusUdgivet - 2020

Bibliografisk note

© 2019 S. Karger AG, Basel.

ID: 58409395